Please login to the form below

Not currently logged in
Email:
Password:

2015

This page shows the latest 2015 news and features for those working in and with pharma, biotech and healthcare.

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

BMS claims rapid FDA nod for Opdivo plus Yervoy in kidney cancer

drug. Opdivo and Yervoy have already shown their worth in melanoma, with BMS claiming approval for the combination in that form of skin cancer in 2015, and is also being tested

Latest news

  • Sanofi sells European generics to Advent for $2.4bn Sanofi sells European generics to Advent for $2.4bn

    Under Brandicourt, the French group has already divested its animal health business via a 22.8bn asset-swap deal with Boehringer Ingelheim in 2015 that bolstered Sanofi’s consumer health unit.

  • AZ taps Ionis for another drug, this time in NASH AZ taps Ionis for another drug, this time in NASH

    It’s the third time AZ has taken up an option on an Ionis drug under a 2015 alliance in the area of cardiovascular, metabolic and kidney disease, after earlier deals ... AZD4076 was a microRNA-targeting oligonucleotide licensed by AZ in 2015 for $28m

  • The Digital Patient The Digital Patient

    Earlier this year, the European Commission published a broad-ranging plan to digitise EU industries to help usher in what has become known as the fourth industrial revolution.

  • UK biotech beats fundraising records in 2015, says BIA UK biotech beats fundraising records in 2015, says BIA

    UK biotech beats fundraising records in 2015, says BIA. Record-breaking amount accounts for a third of all EU biotech venture finance last year. ... Despite a cooling-off in initial public offering (IPO) activity of late, UK companies accounted for more

  • Rare disease therapies head the ‘class of 2015’ Rare disease therapies head the ‘class of 2015

    A product in a new class of cancer therapies that harness the power of viruses also debuted in 2015. ... 31 of the 44 NMEs approved during 2015 were given the nod by the US [FDA] regulator first.

More from news
Approximately 14 fully matching, plus 1,011 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 225 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 318 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 208 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics